1. Home
  2. EVOK vs PAVM Comparison

EVOK vs PAVM Comparison

Compare EVOK & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • PAVM
  • Stock Information
  • Founded
  • EVOK 2007
  • PAVM 2014
  • Country
  • EVOK United States
  • PAVM United States
  • Employees
  • EVOK N/A
  • PAVM N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • PAVM Medical/Dental Instruments
  • Sector
  • EVOK Health Care
  • PAVM Health Care
  • Exchange
  • EVOK Nasdaq
  • PAVM Nasdaq
  • Market Cap
  • EVOK 7.1M
  • PAVM 7.2M
  • IPO Year
  • EVOK 2013
  • PAVM 2016
  • Fundamental
  • Price
  • EVOK $4.81
  • PAVM $0.61
  • Analyst Decision
  • EVOK
  • PAVM Strong Buy
  • Analyst Count
  • EVOK 0
  • PAVM 1
  • Target Price
  • EVOK N/A
  • PAVM $19.00
  • AVG Volume (30 Days)
  • EVOK 10.0K
  • PAVM 121.2K
  • Earning Date
  • EVOK 03-13-2025
  • PAVM 03-25-2025
  • Dividend Yield
  • EVOK N/A
  • PAVM N/A
  • EPS Growth
  • EVOK N/A
  • PAVM N/A
  • EPS
  • EVOK N/A
  • PAVM 0.53
  • Revenue
  • EVOK $8,617,036.00
  • PAVM $4,034,000.00
  • Revenue This Year
  • EVOK $97.35
  • PAVM $52.90
  • Revenue Next Year
  • EVOK $99.52
  • PAVM $248.84
  • P/E Ratio
  • EVOK N/A
  • PAVM $1.17
  • Revenue Growth
  • EVOK 100.35
  • PAVM 166.27
  • 52 Week Low
  • EVOK $3.54
  • PAVM $0.57
  • 52 Week High
  • EVOK $12.32
  • PAVM $3.50
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 59.77
  • PAVM 39.43
  • Support Level
  • EVOK $4.68
  • PAVM $0.62
  • Resistance Level
  • EVOK $4.94
  • PAVM $0.66
  • Average True Range (ATR)
  • EVOK 0.28
  • PAVM 0.05
  • MACD
  • EVOK 0.06
  • PAVM 0.01
  • Stochastic Oscillator
  • EVOK 73.58
  • PAVM 33.52

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Share on Social Networks: